Johnson & Johnson Innovation – JJDC — Full Portfolio

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.

BiotechHealthtech

Anthony Fordin

Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupNew Leaf Venture PartnersPappas Capital+2 more

Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.

HealthtechMedical DevicesGalway, IE

Brendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)

Co-investorsSeroba Life Sciences

Mestag Therapeutics is an immunology company developing first-in-class agonist antibody therapies for cancer and inflammatory diseases based on fibroblast biology, and operates a RAFT platform for discovering new drug targets.

AI & Machine LearningBiotechHealthtech

Susan Hill(Founder & Chief Executive Officer)Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)Soumya Raychaudhuri(Founder)David A. Tuveson(Founder)

Co-investorsGV (Google Ventures)ForbionNorthpond VenturesSV Health Investors

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

David Zacks(Co-Founder & Chief Scientific Officer)David Esposito(Executive Officer, Director)Constance Chang(Executive Officer)John K Freshley(Executive Officer, Director)Jeffrey A Jamison(Executive Officer)David N Zacks(Executive Officer, Director)

Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesBios PartnersInFocus Capital Partners, LLC+3 more

Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.

BiotechHealthtechMedical Devices

Co-investorsArboretum VenturesMaverick Ventures IsraelVisionary VenturesCatalio Capital ManagementLifeSci Venture PartnersSequoia Capital+1 more

SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease.

AI & Machine LearningDeep TechHealthtechMedical DevicesBedford, US

Eman Namati(President & CEO)Guillermo Tearney(Founder; Professor of Pathology, Massachusetts General Hospital)Gregg Stone(Founder; Professor of Medicine, Mount Sinai Heart Health System)James Muller(Founder; Cardiologist, Brigham and Women's Hospital)Jeffrey O'Donnell(Founder; Managing General Partner, Runway Healthcare)Vivek Walimbe(Chief Operating Officer)

Co-investorsLumira VenturesS3 VenturesSV Health InvestorsDeerfield Management Company

Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.

BiotechDeep TechHealthtechGaithersburg, US

Samir N. Khleif(Founder & CEO)Ramy Ibrahim(Chief Medical and Strategy Officer)Mikayel Mkrichyan(Senior Vice President of Science and Discovery)Sarah Sharman(Vice President of IP Legal Affairs)

BoardSean Parker(Director)Elena Viboch(Director)

Board seatNancy Ondovik· per SEC Form D · $131.9M raise · filed Aug 2026

Co-investorsCatalio Capital Management, LPHAWKTAILLauder PartnersPrevail Venture CapitalGeneral Catalyst

Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.

BiotechHealthtechLongevity

Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupJJDC+1 more

ARO Network is an edge network infrastructure platform designed for AI agents to operate on local devices and residential networks using users' real-world resources.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Co-investorsCVP NoLimitEv3 Ventures LlcNo Limit Holdings (NLH)17SigmaNorte VenturesOnevc Venture Partners Llc

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.

BiotechHealthtech

Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesSeroba Life SciencesVenture OntarioYsios Capital+2 more

HealthtechHouston, US

Joanna Nathan(Executive Officer, Director)

BoardMicheal Haimour(Director)Ed Boyle(Director)Sean Churchill(Director)

Co-investorsHouston Angel NetworkNew World AngelsTMC Venture Fund

Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.

Medical DevicesCollege Station, US

James Y Lancaster(Executive Officer, Director)

BoardJohn Hodock(Director)Robert Calvin Goforth(Director)

Co-investorsShangBay Capital LLCSugati Ventures

HealthtechStamford, US

Patrick Lopath(Chief Operating Officer)Thomas Alan Dunlap(Chief Executive Officer)Madhu Ayyagari(Chief Executive Officer)

BoardRichel Liu(Director)Deng Mao(Director)Hirak Parikh(Director)

Astoria, US

Demetrius Michael Karagas(Executive Officer, Director)Steven Craig Gutentag(Executive Officer, Director)Steven Gutentag(Founder)in

BoardRebecca Kaden(Director)in

Co-investorsComcast VenturesConnetic VenturesCVS Health VenturesEvolution VC PartnersForeground CapitalGreycroft+11 more

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

Ryan Sysko(Executive Officer, Director)Suzanne Clough(Executive Officer)Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)Chris Bergstrom(Executive Officer)Anand K. Iyer(Executive Officer)

Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementTCP Venture Capital+1 more